(Q37864145)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21484293%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

review article

1 reference

title

Experimental models for the investigation of high-density lipoprotein-mediated cholesterol efflux (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21484293%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

Carlos G Santos-Gallego

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21484293%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

Chiara Giannarelli

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21484293%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Juan José Badimón

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21484293%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

language of work or name

1 reference

1 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21484293%20AND%20SRC:MED&resulttype=core&format=json

Current Atherosclerosis Reports

28 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21484293%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21484293%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21484293%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

266-276

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21484293%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11883-011-0177-0

28 January 2020

exact match

0 references

cites work

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0177-0

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0177-0

HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0177-0

A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0177-0

Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0177-0

Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0177-0

Differential effects of scavenger receptor BI deficiency on lipid metabolism in cells of the arterial wall and in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0177-0

Effect of torcetrapib on the progression of coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0177-0

Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0177-0

Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0177-0

Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0177-0

Endothelial and antithrombotic actions of HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0177-0

HDL-cholesterol: is it really good? Differences between apoA-I and HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0177-0

Adipocyte modulation of high-density lipoprotein cholesterol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0177-0

Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0177-0

Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0177-0

Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0177-0

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0177-0

Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I. Potential reverse cholesterol transport in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0177-0

Hepatobiliary cholesterol transport is not impaired in Abca1-null mice lacking HDL

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0177-0

The effect of cholesteryl ester transfer protein overexpression and inhibition on reverse cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0177-0

Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0177-0

Cholesterol net transport, esterification, and transfer in human hyperlipidemic plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0177-0

Ability of serum to decrease cellular acylCoA:cholesterol acyl transferase activity predicts cardiovascular outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0177-0

Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0177-0

Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0177-0

Increased ABCA1 activity protects against atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0177-0

Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0177-0

Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0177-0

Cholesterol absorption from the intestine is a major determinant of reverse cholesterol transport from peripheral tissue macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0177-0

Centripetal cholesterol flux from extrahepatic organs to the liver is independent of the concentration of high density lipoprotein-cholesterol in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0177-0

The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0177-0

High-density lipoprotein cholesterol and premature coronary heart disease in urban Japanese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0177-0

Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0177-0

Value of HDL cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I/A-II in prediction of coronary heart disease: the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0177-0

Importance of HDL cholesterol in atherothrombosis: how did we get here? Where are we going?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-011-0177-0

Centripetal cholesterol flux to the liver is dictated by events in the peripheral organs and not by the plasma high density lipoprotein or apolipoprotein A-I concentration

21 January 2018

1 reference

12 December 2020

In vivo macrophage-specific RCT and antioxidant and antiinflammatory HDL activity measurements: New tools for predicting HDL atheroprotection

1 reference

12 December 2020

Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8000 men

1 reference

12 December 2020

Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches

1 reference

12 December 2020

Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

1 reference

12 December 2020

Lipid Research Clinics Program

1 reference

12 December 2020

High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport

1 reference

12 December 2020

A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification, and transfer

1 reference

12 December 2020

The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages

1 reference

12 December 2020

Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group

1 reference

12 December 2020

Transintestinal cholesterol efflux

1 reference

12 December 2020

A simplified micro-method for quantification of fecal excretion of neutral and acidic sterols for outpatient studies in humans

1 reference

12 December 2020